Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T02:27:30.274Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of hexokinase 2 (HK2) in modulating tumor metabolism and response to therapy in glioblastoma

Published online by Cambridge University Press:  30 October 2014

A. Vartanian ,
K. Burrell ,
S.K. Singh ,
S. Jalali ,
S. Agnihotri  and
G. Zadeh
A. Vartanian
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
K. Burrell
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
S.K. Singh
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
S. Jalali
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
S. Agnihotri
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
G. Zadeh
Affiliation:
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Scientific Oral Presentations 13 June 2014
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue s2: 16th Biennial Canadian Neuro-Oncology Meeting , October 2014 , pp. S2
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2014